TERRACCIANO, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 2.464
EU - Europa 1.016
AS - Asia 611
SA - Sud America 140
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 4.240
Nazione #
US - Stati Uniti d'America 2.438
IT - Italia 320
CN - Cina 216
SG - Singapore 209
RU - Federazione Russa 185
DE - Germania 151
UA - Ucraina 140
BR - Brasile 128
HK - Hong Kong 61
IE - Irlanda 61
TR - Turchia 55
SE - Svezia 45
FI - Finlandia 42
KR - Corea 30
GB - Regno Unito 19
CA - Canada 16
NL - Olanda 15
CZ - Repubblica Ceca 12
VN - Vietnam 12
IN - India 10
AT - Austria 8
ES - Italia 6
MX - Messico 6
AZ - Azerbaigian 4
PL - Polonia 4
UZ - Uzbekistan 4
AR - Argentina 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CO - Colombia 2
EC - Ecuador 2
EU - Europa 2
FR - Francia 2
GT - Guatemala 2
MA - Marocco 2
PK - Pakistan 2
UY - Uruguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
KZ - Kazakistan 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.240
Città #
Ann Arbor 579
Chandler 306
Woodbridge 236
Jacksonville 173
Wilmington 170
Princeton 166
Houston 150
Ashburn 99
Salerno 93
Singapore 84
Dublin 60
Hong Kong 59
Izmir 53
Munich 47
Nanjing 45
Beijing 41
Andover 35
Boardman 30
Dearborn 29
Pellezzano 28
Moscow 24
Fisciano 19
Naples 19
Redwood City 17
Guangzhou 16
Fairfield 15
Turku 15
Nuremberg 14
Dong Ket 12
Jiaxing 12
The Dalles 12
Changsha 11
Columbus 11
Hebei 11
Brno 10
Los Angeles 9
Nanchang 9
New York 9
Dallas 8
Düsseldorf 8
Mestre 8
Seattle 8
Shenyang 8
Washington 8
Montreal 7
Norwalk 7
Pune 7
São Paulo 7
Ottawa 6
Amsterdam 5
Belo Horizonte 5
Caianello 5
Falls Church 5
Jinan 5
Nürnberg 5
Arzano 4
Brooklyn 4
Chicago 4
Council Bluffs 4
Mexico City 4
Nocera Superiore 4
Pignola 4
Pomigliano d'Arco 4
Pozzuoli 4
San Diego 4
San Francisco 4
Tianjin 4
Yubileyny 4
Baku 3
Boston 3
Campinas 3
Charlotte 3
Chengdu 3
Chennai 3
Cormano 3
Curitiba 3
Edinburgh 3
Florianópolis 3
Granada 3
Guarulhos 3
Johannesburg 3
London 3
Manaus 3
Messina 3
Phoenix 3
Recife 3
Stockholm 3
Taranto 3
Tashkent 3
Vienna 3
Acerra 2
Assago 2
Aversa 2
Bari 2
Barra do Choça 2
Bonea 2
Centro 2
Denver 2
Donostia / San Sebastian 2
Dormagen 2
Totale 2.978
Nome #
9H-purine scaffold reveals induced-fit pocket plasticity of the BRD9 bromodomain 169
Can Small Chemical Modifications of Natural Pan-inhibitors Modulate the Biological Selectivity? the Case of Curcumin Prenylated Derivatives Acting as HDAC or mPGES-1 Inhibitors 147
40 th "A. Corbella" International Summer School on Organic Synthesis - ISOS 2015 137
Dimeric and trimeric triazole based molecules as a new class of Hsp90 molecular chaperone inhibitors 121
Targeting the Hsp90 C-terminal domain by the chemically accessible dihydropyrimidinone scaffold 121
Design and Synthesis of cyclopeptide analogues of the potent Histone deacetylase inhibitor FR235222 117
Design, Synthesis, and Biological Activity of Hydroxamic Tertiary Amines as Histone Deacetylase Inhibitors 115
Synthesis, Conformational Analysis, and Cytotoxicity of New Analogues of the Natural Cyclodepsipeptide Jaspamide 114
Identification of novel microsomal prostaglandin E2 synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening 112
Correction: Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 109
New dihydropyrimidin-2(1H)-one based Hsp90 C-terminal inhibitors 108
Chemistry and biology of anti-inflammatory marine natural products: molecules interfering with cyclooxygenase, NF-κB and other unidentified targets 107
Design,virtual Screening and Synthesis of Potential Microsomal Prostaglandine E2 Synthase-1 (mPGES-1)Inhibitors 103
Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1) 102
Molecular modeling studies toward the structural optimization of new cyclopeptide-based HDAC inhibitors modeled on the natural product FR235222 101
Total Synthesis, NMR Solution Structure, and Binding Model of the Potent Histone Deacetylase Inhibitor FR235222 100
Structural Insights for the Optimization of Dihydropyrimidin-2(1H)-one Based mPGES-1 Inhibitors 98
Targeting Microsomal Prostaglanding E2 Synthase 1 for the Development of new potential Anti-Inflammatory Drugs 98
Conformationally locked calixarene-based histone deacetylase inhibitors 95
Synthesis of new mono and bis amides projected as potential histone deacetylase (HDAC) inhibitors 94
Hsp90 Activity Modulation by Plant Secondary Metabolites 91
Discovery of new potent molecular entities able to inhibit mPGES-1 89
A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4-Thiazolidinedione-Based Molecules as New Dual mPGES-1/5-LO Inhibitors 87
Structure-Based Design of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) Inhibitors using a Virtual Fragment Growing Optimization Scheme 86
Chemistry and Biology of Anti-Inflammatory Marine Natural Products.Phospholipase A2 Inhibitors 85
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222 81
Identification of Lead Compounds as Inhibitors of STAT3: Design, Synthesis and Bioactivity 81
Identification of the key structural elements of a dihydropyrimidinone core driving toward more potent Hsp90 C-terminal inhibitors 81
Cyclic Peptoids as Mycotoxin Mimics: An Exploration of Their Structural and Biological Properties 80
Discovery and synthesis of the first selective BAG domain modulator of BAG3 as an attractive candidate for the development of a new class of chemotherapeutics 79
Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain 78
Structural basis for the design and synthesis of selective HDAC inhibitors 77
Critical Surveys Covering the Year 2004:Total Synthesis of Natural Products 76
Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide 74
Inhibition of Microsomal Prostaglandin E2 Synthase 1: focused design of new anti-inflammatory and anti-cancer drugs 72
Effects of FR235222, a novel HDAC inhibitor, in proliferation and apoptosis of human leukaemia cell lines: role of annexin A1 70
Identification of 2,4,5-trisubstituted-2,4-dihydro-3H-1,2,4-triazol-3-one-based small molecules as selective BRD9 binders 68
Identification of the 2-Benzoxazol-2-yl-phenol Scaffold as New Hit for JMJD3 Inhibition 61
Discovery of noscapine derivatives as potential β-tubulin inhibitors 61
Synthesis, solution structure, and bioactivity of six new simplified analogues of the natural cyclodepsipeptide jaspamide 56
Identification by Inverse Virtual Screening of magnolol-based scaffold as new tankyrase-2 inhibitors 56
Structural Refinement of 2,4-Thiazolidinedione Derivatives as New Anticancer Agents Able to Modulate the BAG3 Protein 51
Glucopyranosylbianthrones from the Algerian Asphodelus tenuifolius: Structural Insights and Biological Evaluation on Melanoma Cancer Cells 45
Repositioning of Quinazolinedione-Based Compounds on Soluble Epoxide Hydrolase (sEH) through 3D Structure-Based Pharmacophore Model-Driven Investigation 42
Introducing structure-based three-dimensional pharmacophore models for accelerating the discovery of selective BRD9 binders 41
Chemoproteomics Reveals USP5 (Ubiquitin Carboxyl-Terminal Hydrolase 5) as Promising Target of the Marine Polyketide Gracilioether A 40
2-Substituted 1,5-benzothiazepine-based HDAC inhibitors exert anticancer activities on human solid and acute myeloid leukemia cell lines 36
Protein Preparation Automatic Protocol for High-Throughput Inverse Virtual Screening: Accelerating the Target Identification by Computational Methods 36
Targeting mPGES-1 by a Combinatorial Approach: Identification of the Aminobenzothiazole Scaffold to Suppress PGE2Levels 30
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 29
From Natural Compounds to Bioactive Molecules through NMR and In Silico Methodologies 26
Identification of 2,4-Dinitro-Biphenyl-Based Compounds as MAPEG Inhibitors 26
Identification of 2-(thiophen-2-yl)acetic Acid-Based Lead Compound for mPGES-1 Inhibition 25
Identification of a New Promising BAG3 Modulator Featuring the Imidazopyridine Scaffold 19
Exploring the chemical space of functionalized [1,2,4]triazolo[4,3-a]quinoxaline-based compounds targeting the bromodomain of BRD9 17
Identification of the first-in-class dual inhibitor targeting BAG3 and HSP70 proteins to disrupt multiple chaperone pathways 12
In Silico Design, Chemical Synthesis, Biophysical and in Vitro Evaluation for the Identification of 1-Ethyl-1H-Pyrazolo[3,4-b]Pyridine-Based BRD9 Binders 11
Virtual screening of 3-(1H-1,2,3-triazol-1-yl)piperidine-2,6-dione-based compounds as new potential Cereblon modulators amenable for targeted protein degradation 11
Identification of 2-Aminoacyl-1,3,4-thiadiazoles as Prostaglandin E2 and Leukotriene Biosynthesis Inhibitors 11
Identification of Novel Bromodomain-Containing Protein 4 (BRD4) Binders through 3D Pharmacophore-Based Repositioning Screening Campaign 11
Identification of Honokiol-Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies 8
Totale 4.384
Categoria #
all - tutte 17.387
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.387


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021293 4 26 29 2 39 21 40 4 59 7 36 26
2021/2022315 4 0 0 5 9 8 10 11 49 38 45 136
2022/2023641 52 73 18 106 65 121 5 67 81 0 35 18
2023/2024288 20 42 20 12 38 54 13 22 6 8 10 43
2024/2025951 30 7 6 43 28 80 230 65 129 47 123 163
2025/202636 36 0 0 0 0 0 0 0 0 0 0 0
Totale 4.384